Company will host a business update conference call on February 19, 2019 at 4:30 PM Eastern Time VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 12, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq:… Read More
CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial Vancouver, Canada – February 11, 2019: CDRD, Canada’s national life sciences venture, is pleased to announce an… Read More
Vancouver, BC and Menlo Park, CA Feb. 7, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies,… Read More
UNIVERSITY NEWS Jan 31, 2019 | For more information, contact Matthew Ramsey The University of British Columbia has appointed Robin Ciceri as the new Vice-President, External Relations, effective March 1, 2019. Ciceri… Read More
3D Bioprinted Meniscus Tissue From Biocompatible Materials Displays Appropriate Biomechanical Properties for Surgical Implantation and Physiological Function VANCOUVER, BC — Aspect Biosystems Ltd., a Canadian biotech company pioneering microfluidic 3D bioprinting… Read More
